CoChat

Gradual Drug Release Membranes and Films Used for the Treatment of Periodontal Disease

Petrescu, Nausica, Crisan, Bogdan, Aghiorghiesei, Ovidiu, Sarosi, Codruta, Mirica, Ioana Codruta, Lucaciu, Ondine, Iușan, Simina Angela Lăcrimioara, Dirzu, Noemi, Apostu, Dragos · 2022 · Membranes
Cited by 14

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Periodontitis is an inflammatory disease that, if not treated, can cause a lot of harm to the oral cavity, to the patients’ quality of life, and to the entire community. There is no predictable standardized treatment for periodontitis, but there have been many attempts, using antibiotics, tissue regeneration techniques, dental scaling, or root planning. Due to the limits of the above-mentioned treatment, the future seems to be local drug delivery systems, which could gradually release antibiotics and tissue regeneration inducers at the same time. Local gradual release of antibiotics proved to be more efficient than systemic administration. In this review, we have made a literature search to identify the articles related to this topic and to find out which carriers have been tested for drug release as an adjuvant in the treatment of periodontitis. Considering the inclusion and exclusion criteria, 12 articles were chosen to be part of this review. The selected articles indicated that the drug-releasing carriers in periodontitis treatment were membranes and films fabricated from different types of materials and through various methods. Some of the drugs released by the films and membranes in the selected articles include doxycycline, tetracycline, metronidazole, levofloxacin, and minocycline, all used with good outcome regarding their bactericide effect; BMP-2, Zinc–hydroxyapatite nanoparticles with regenerative effect. The conclusion derived from the selected studies was that gradual drug release in the periodontal pockets is a promising strategy as an adjuvant for the treatment of periodontal disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/membranes12090895

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 68

  1. Kolenbrander, 2006, Bacterial interactions and successions during plaque development, Periodontol. 2000, 42, 47, 10.1111/j.1600-0757.2006.00187.x · DOI · Paper page
  2. Page, 1997, The pathogenesis of human periodontitis: An introduction, Periodontol. 2000, 14, 9, 10.1111/j.1600-0757.1997.tb00189.x · DOI · Paper page
  3. Kassebaum, 2014, Global burden of severe periodontitis in 1990–2010: A systematic review and meta-regression, J. Dent. Res., 93, 1045, 10.1177/0022034514552491 · DOI · Paper page
  4. Petersen, 2012, The global burden of periodontal disease: Towards integration with chronic disease prevention and control, Periodontol. 2000, 60, 15, 10.1111/j.1600-0757.2011.00425.x · DOI · Paper page
  5. Campoccia, 2013, A review of the biomaterials technologies for infection-resistant surfaces, Biomaterials, 34, 8533, 10.1016/j.biomaterials.2013.07.089 · DOI · Paper page
  6. Botelho, 2021, Economic Burden of Periodontal Disease in Europe and the United States of America—An updated forecast, medRxiv, 93, 373
  7. Monsarrat, 2016, Clinical research activity in periodontal medicine: A systematic mapping of trial registers, J. Clin. Periodontol., 43, 390, 10.1111/jcpe.12534 · DOI · Paper page
  8. Hansen, 2016, Relation of Periodontitis to Risk of Cardiovascular and All-Cause Mortality (from a Danish Nationwide Cohort Study), Am. J. Cardiol., 118, 489, 10.1016/j.amjcard.2016.05.036 · DOI
  9. Trombelli, 2002, A systematic review of the effect of surgical debridement vs non-surgical debridement for the treatment of chronic periodontitis, J. Clin. Periodontol., 29, 92, 10.1034/j.1600-051X.29.s3.5.x · DOI · Paper page
  10. Nowzari, 1995, Periodontal pathogens on polytetrafluoroethylene membrane for guided tissue regeneration inhibit healing, J. Clin. Periodontol., 22, 469, 10.1111/j.1600-051X.1995.tb00179.x · DOI
  11. Sunal, 2019, Chitosan-based double-faced barrier membrane coated with functional nanostructures and loaded with BMP-6, J. Mater. Sci. Mater. Med., 31, 4
  12. Sariibrahimoglu, 2015, Development of porous polyurethane/strontium-substituted hydroxyapatite composites for bone regeneration, J. Biomed. Mater. Res. A, 103, 1930, 10.1002/jbm.a.35327 · DOI
  13. Bottino, 2011, A novel spatially designed and functionally graded electrospun membrane for periodontal regeneration, Acta Biomater., 7, 216, 10.1016/j.actbio.2010.08.019 · DOI · Paper page
  14. Korkusuz, 2001, In vivo response to biodegradable controlled antibiotic release systems, Biomed. Mater. Res., 55, 217, 10.1002/1097-4636(200105)55:2<217::AID-JBM1008>3.0.CO;2-Y · doi:10.1002/1097-4636(200105)55:2<217::aid-jbm1008>3.0.co;2-y
  15. Taubes, 2008, The bacteria fight back, Science, 321, 356, 10.1126/science.321.5887.356 · DOI · Paper page
  16. Rams, 1996, Local delivery of antimicrobial agents in the periodontal pocket, Periodontol. 2000, 10, 139, 10.1111/j.1600-0757.1996.tb00072.x · DOI · Paper page
  17. Jorge, 2006, In vitro minocycline activity on superinfecting microorganisms isolated from chronic periodontitis patients, Braz. Oral Res., 20, 202, 10.1590/S1806-83242006000300004 · DOI · Paper page
  18. Rajendra, 2016, Antibiotics in aggressive periodontitis, is there a clinical benefit?, Evid.-Based Dent., 17, 100, 10.1038/sj.ebd.6401197 · doi:10.1038/sj.ebd.6401197
  19. Lecio, 2020, Novel 20% doxycycline-loaded PLGA nanospheres as adjunctive therapy in chronic periodontitis in type-2 diabetics: Randomized clinical, immune and microbiological trial, Clin. Oral Investig., 24, 1269, 10.1007/s00784-019-03005-9 · DOI
  20. Chang, 2008, Controlled release of an antibiotic, gentamicin sulphate, from gravity spun polycaprolactone fibers, J. Biomed. Mater. Res. A, 84, 230, 10.1002/jbm.a.31476 · doi:10.1002/jbm.a.31476
  21. Higashi, 1991, Local drug delivery systems for the treatment of periodontal disease, J. Pharmacobiodyn., 14, 72, 10.1248/bpb1978.14.72 · doi:10.1248/bpb1978.14.72
  22. Steinberg, 2020, Sustained-release delivery of antimicrobial drugs for the treatment of periodontal diseases: Fantasy or already reality?, Periodontol. 2000, 84, 176, 10.1111/prd.12341 · DOI
  23. Steinberg, 1990, A new degradable controlled release device for treatment of periodontal disease: In vitro release study, J. Periodontol., 61, 393, 10.1902/jop.1990.61.7.393 · DOI
  24. Fadaie, 2018, Incorporation of nanofibrillated chitosan into electrospun PCL nanofibers makes scaffolds with enhanced mechanical and biological properties, Carbohydr. Polym., 199, 628, 10.1016/j.carbpol.2018.07.061 · DOI
  25. Chen, 2020, Mussel-inspired polydopamine-assisted bromelain immobilization onto electrospun fibrous membrane for potential application as wound dressing, Mater. Sci. Eng. C Mater. Biol. Appl., 110, 110624, 10.1016/j.msec.2019.110624 · DOI
  26. Jin, 2013, Tissue engineered plant extracts as nanofibrous wound dressing, Biomaterials, 34, 724, 10.1016/j.biomaterials.2012.10.026 · DOI · Paper page
  27. Lan, 2021, Multidrug-loaded electrospun micro/nanofibrous membranes: Fabrication strategies, release behaviors and applications in regenerative medicine, J. Control. Release, 330, 1264, 10.1016/j.jconrel.2020.11.036 · DOI
  28. Mahajania, 2018, Effect of Subgingival Doxycycline Placement on Clinical and Microbiological Parameters in Inflammatory Periodontal Disease: Both in Vivo and in Vitro Studies, J. Contemp. Dent. Pract., 19, 1228, 10.5005/jp-journals-10024-2409 · doi:10.5005/jp-journals-10024-2409
  29. Gamal, 2012, A novel approach to the use of doxycycline-loaded biodegradable membrane and EDTA root surface etching in chronic periodontitis: A randomized clinical trial, J. Periodontol., 83, 1086, 10.1902/jop.2011.110476 · doi:10.1902/jop.2011.110476
  30. Khan, 2015, Development and Evaluation of Biodegradable Chitosan Films of Metronidazole and Levofloxacin for the Management of Periodontitis, AAPS PharmSciTech, 17, 1312, 10.1208/s12249-015-0466-y · DOI
  31. Kassem, 2015, Preparation and evaluation of periodontal films based on polyelectrolyte complex formation, Pharm. Dev. Technol., 20, 297, 10.3109/10837450.2013.862262 · DOI
  32. Liu, 2020, One-step treatment of periodontitis based on a core-shell micelle-in-nanofiber membrane with time-programmed drug release, J. Control. Release, 320, 201, 10.1016/j.jconrel.2020.01.045 · DOI
  33. Khajuria, 2018, Development and evaluation of novel biodegradable chitosan based metformin intrapocket dental film for the management of periodontitis and alveolar bone loss in a rat model, Arch. Oral Biol., 85, 120, 10.1016/j.archoralbio.2017.10.009 · DOI
  34. Khajuria, 2017, Effect of locally administered novel biodegradable chitosan based risedronate/zinc-hydroxyapatite intra-pocket dental film on alveolar bone density in rat model of periodontitis, J. Biomater. Sci. Polym., 29, 74, 10.1080/09205063.2017.1400145 · DOI
  35. Ho, 2021, The treatment response of barrier membrane with amoxicillin-loaded nanofibers in experimental periodontitis, J. Periodontol., 92, 886, 10.1002/JPER.20-0256 · DOI
  36. Wu, 2021, Multifunctional chitin-based barrier membrane with antibacterial and osteogenic activities for the treatment of periodontal disease, Carbohydr. Polym., 269, 118276, 10.1016/j.carbpol.2021.118276 · DOI
  37. Li, 2019, An enzyme-responsive membrane for antibiotic drug release and local periodontal treatment, Colloids Surf. B Biointerfaces, 183, 110454, 10.1016/j.colsurfb.2019.110454 · DOI
  38. Choung, 2019, The effect of CPNE7 on periodontal regeneration, Connect. Tissue Res., 60, 419, 10.1080/03008207.2019.1574776 · doi:10.1080/03008207.2019.1574776
  39. Ionel, 2016, Assessment of the relationship between periodontal disease and cardiovascular disorders: A questionnaire-based study, Clujul Med., 89, 534
  40. Ionel, 2015, Periodontal disease induced in Wistar rats—Experimental study, HVM Bioflux, 7, 90
  41. Satheesh, 2017, Successful Strategies for Periodontal Debridement, Dimensions of Dental Hygiene, Dimens. Dent. Hyg., 15, 39
  42. 2019, Systemic antibiotics in the treatment of periodontitis, Dent. Med. Res., 7, 33, 10.4103/dmr.dmr_23_19 · DOI
  43. Bogdanovska, 2012, Therapeutic strategies in the treatment of periodontitis. Macedonian pharmaceutical bulletin, Maced. Pharm. Bull., 58, 3, 10.33320/maced.pharm.bull.2012.58.001 · DOI
  44. Bailey, 1997, Local drug delivery: Current applications, Prog. Cardiovasc. Dis., 40, 183, 10.1016/S0033-0620(97)80008-4 · DOI
  45. Larsson, 2016, Regenerative Medicine for Periodontal and Peri-implant Diseases, J. Dent. Res., 95, 255, 10.1177/0022034515618887 · DOI · Paper page
  46. Osorio, R., Alfonso-Rodríguez, C.A., Medina-Castillo, A.L., Alaminos, M., and Toledano, M. (2016). Bioactive Polymeric Nanoparticles for Periodontal Therapy. PLoS ONE, 11. · DOI
  47. Gottlow, 1984, New attachment formation as the result of controlled tissue regeneration, J. Clin. Periodontol., 11, 494, 10.1111/j.1600-051X.1984.tb00901.x · doi:10.1111/j.1600-051x.1984.tb00901.x
  48. Tsalikis, 2014, Effects of doxycycline on clinical, microbiological and immunological parameters in well-controlled diabetes type-2 patients with periodontal disease: A randomized, controlled clinical trial, J. Clin. Periodontol., 41, 972, 10.1111/jcpe.12287 · DOI
  49. Stabholz, 1986, Clinical and microbiological effects of sustained release chlorhexidine in periodontal pockets, J. Clin. Periodontol., 13, 783, 10.1111/j.1600-051X.1986.tb00882.x · DOI
  50. Ahamed, 2013, The Use of Controlled Release Locally Delivered 10% Doxycycline Hyclate Gel as an adjunct to Scaling and Root Planing in the Treatment of Chronic Periodontitis: Clinical and Microbiological Results, J. Contemp. Dent. Pract., 14, 1080, 10.5005/jp-journals-10024-1455 · DOI
  51. Kida, D., Karolewicz, B., Junka, A., Sender-Janeczek, A., Duś, I., Marciniak, D., and Szulc, M. (2019). Metronidazole-Loaded Porous Matrices for Local Periodontitis Treatment: In Vitro Evaluation and In Vivo Pilot. Study Appl. Sci., 9. · doi:10.3390/app9214545
  52. Paradowska-Stolarz, A., Wieckiewicz, M., Owczarek, A., and Wezgowiec, J. (2021). Natural Polymers for the Maintenance of Oral Health: Review of Recent Advances and Perspectives. Int. J. Mol. Sci., 22. · DOI
  53. Wirth, 2021, Toward Personalized Oral Diagnosis: Distinct Microbiome Clusters in Periodontitis Biofilms, Front. Cell. Infect. Microbiol., 11, 747814, 10.3389/fcimb.2021.747814 · DOI
  54. Miron, 2017, Use of platelet-rich fibrin in regenerative dentistry: A systematic review, Clin. Oral Investig., 21, 1913, 10.1007/s00784-017-2133-z · DOI
  55. Choukroun, 2006, Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol., 101, e56, 10.1016/j.tripleo.2005.07.011 · DOI
  56. Egle, K., Salma, I., and Dubnika, A. (2021). From Blood to Regenerative Tissue: How Autologous Platelet-Rich Fibrin Can Be Combined with Other Materials to Ensure Controlled Drug and Growth Factor Release. Int. J. Mol. Sci., 22. · DOI
  57. Coelho, 2021, Platelet activation and antimicrobial activity of L-PRF: A preliminary study, Mol. Biol. Rep., 48, 4573, 10.1007/s11033-021-06487-7 · DOI
  58. Fan, 2020, Clinical Uses of Platelet-Rich Fibrin in Oral and Maxillofacial Surgery, Dent. Clin. N. Am., 64, 291, 10.1016/j.cden.2019.12.012 · DOI
  59. Karimi, 2019, The Benefits of Platelet-Rich Fibrin, Facial Plast. Surg. Clin. N. Am., 27, 331, 10.1016/j.fsc.2019.03.005 · DOI · Paper page
  60. Egle, K., Skadins, I., Grava, A., Micko, L., Dubniks, V., Salma, I., and Dubnika, A. (2022). Injectable Platelet-Rich Fibrin as a Drug Carrier Increases the Antibacterial Susceptibility of Antibiotic-Clindamycin Phosphate. Int. J. Mol. Sci., 23. · DOI
  61. Straub, A., Vollmer, A., Lâm, T.T., Brands, R.C., Stapf, M., Scherf-Clavel, O., Bittrich, M., Fuchs, A., Kübler, A.C., and Hartmann, S. (Clin. Oral. Investig., 2022). Evaluation of advanced platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam, Clin. Oral. Investig., advance online publication. · doi:10.1007/s00784-022-04663-y
  62. Dubnika, A., Egle, K., Skrinda-Melne, M., Skadins, I., Rajadas, J., and Salma, I. (2021). Development of Vancomycin Delivery Systems Based on Autologous 3D Platelet-Rich Fibrin Matrices for Bone Tissue Engineering. Biomedicines, 9. · DOI
  63. Miron, 2018, Autologous liquid platelet rich fibrin: A novel drug delivery system, Acta Biomater., 75, 35, 10.1016/j.actbio.2018.05.021 · DOI
  64. Bertalot, 2018, Leucocyte and Platelet-rich Fibrin: A carrier of autologous multipotent cells for regenerative medicine, J. Cell. Mol. Med., 22, 1840, 10.1111/jcmm.13468 · DOI
  65. Rafiee, 2021, Drug Delivery Assessment of a Novel Triple Antibiotic-Eluting Injectable Platelet-Rich Fibrin Scaffold: An In Vitro Study, Curr. Pharm. Biotechnol., 22, 380
  66. Kuehnel, 2021, Platelet-Rich Fibrin in Combination with Local Antibiotics Optimizes Wound Healing After Deep Sternal Wound Problems and Prevents Reinfection, Surg. Technol. Int., 39, 313, 10.52198/21.STI.39.CV1504 · doi:10.52198/21.sti.39.cv1504
  67. Kornsuthisopon, 2020, Autologous platelet-rich fibrin stimulates canine periodontal regeneration, Sci. Rep., 10, 1850, 10.1038/s41598-020-58732-x · DOI
  68. Bhattacharya, 2020, Novel method of determining the periodontal regenerative capacity of T-PRF and L-PRF: An immunohistochemical study, Dent. Med. Probl., 57, 137, 10.17219/dmp/117721 · doi:10.17219/dmp/117721

Metadata

Authors
Petrescu, N., Crisan, B., Aghiorghiesei, O., Sarosi, C., Mirica, I. C., Lucaciu, O., Iușan, S. A. L., Dirzu, N., & Apostu, D.
Venue
Membranes
Publisher
MDPI AG
Published
2022-09-17
Volume
12
Issue
9
Pages
895
ISSN
2077-0375
Cited by
14
References
5
Language
en
Funders
Ministry of Research, Innovation and Digitization, CNCS–UEFISCD (PN-III-P1-1.1-TE-2021-0531)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gradual Drug Release Membranes and Films Used for the Treatment of Periodontal Disease. https://app.cochat.ai/papers/10.3390/membranes12090895
The paper
Petrescu, N., Crisan, B., Aghiorghiesei, O., Sarosi, C., Mirica, I. C., Lucaciu, O., Iușan, S. A. L., Dirzu, N., & Apostu, D. (2022). Gradual Drug Release Membranes and Films Used for the Treatment of Periodontal Disease. Membranes. https://doi.org/10.3390/membranes12090895

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.